Contributors: Centre de recherche en épidémiologie et santé des populations (CESP); Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay; Cohortes épidémiologiques en population (CONSTANCES); Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay-Université Paris Cité (UPCité); UFR Médecine Santé - Université Paris Cité (UFR Médecine UPCité); Université Paris Cité (UPCité); Hôpital Cochin AP-HP; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP); ANR-11-INBS-0002; AstraZeneca; Meso Scale Diagnostics, MSD; Fondation pour la Recherche Médicale, FRM: ECO202006011654; H. Lundbeck A/S; Conservatoire National des Arts et Métiers, CNAM; The CONSTANCES cohort receives grants from ANR (ANR-11-INBS-0002), the Caisse nationale d'assurance maladie-CNAM and the Ministry of research. CONSTANCES also receives funding from MSD, AstraZeneca, Lundbeck and L'Oréal, managed by INSERM-Transfert. T.Tsiavia is supported by a PhD grant from the Fondation pour le Recherche Médicale (ECO202006011654).; T.Tsiavia, L.Orsi and R.Nadif have verified the underlying data, designed and conducted the study; J.Henny, M.Goldberg, M.Zins, L.Orsi and R.Nadif contributed to the data acquisition; T.Tsiavia, L.Orsi and R.Nadif interpreted the data; T.Tsiavia, L.Orsi and R.Nadif drafted the article; T.Tsiavia, J.Henny, M.Goldberg, M.Zins, N.Roche, L.Orsi and R.Nadif contributed to the critical review of important intellectual content; all authors edited and approved the final manuscript. The authors thank the ?Caisse nationale d'assurance maladie? (CNAM) and the ?Centres d'examens de sant?? of the French Social Security which are collecting a large part of the data, as well as the ?Caisse nationale d'assurance vieillesse?, ClinSearch, Asqualab and Eurocell in charge of the data quality control. The authors thank all those who participated to the setting of the study and on the various aspects of the examinations involved: interviewers, technicians for lung function testing, coders, those involved in quality control, data and sample management and all the staffs from the inclusion centers (HPCs). They are indebted to all the participating individuals without whom the study would not have been possible. The authors also thank S Le Got, S Lemonnier, A Ozguler, C Ribet from Inserm UMS11. The authors are also grateful to Groupe Respiratoire CONSTANCES: MC Delmas, O Dumas, V Giraud, Y Iwatsubo, B Leynaert, N Le Moual, T Perez, R Varraso. The CONSTANCES cohort receives grants from ANR (ANR-11-INBS-0002), the Caisse nationale d'assurance maladie-CNAM and the Ministry of research. CONSTANCES also receives funding from MSD, AstraZeneca, Lundbeck and L'Or?al, managed by INSERM-Transfert. T.Tsiavia is supported by a PhD grant from the Fondation pour le Recherche M?dicale (ECO202006011654). Access to sensitive and personal data, such as those from CONSTANCES cohort, is restricted by French law. The CONSTANCES coordination team makes the data available, upon request, to qualified researchers who have obtained prior authorization from the French national data protection authority (Commission de l'informatique et des libert?s, CNIL). Information for applicants to CONSTANCES data is available on the website: https://www.constances.fr/CFP.pdf. CONSTANCES investigators may be contacted at following address: contact@constances.fr; ANR-11-INBS-0002,CONSTANCES,La cohorte CONSTANCES - Infrastructure épidémiologique ouverte pour la recherche et la surveillance(2011)
نبذة مختصرة : International audience ; Background: Asthma is an inflammatory heterogeneous disease. Asthma inflammatory phenotypes based on blood eosinophil and neutrophil counts have never been identified and characterized in population-based studies.Methods: Adults with current asthma and available blood eosinophil and neutrophil counts from the French population-based CONSTANCES cohort were included. Current asthma was defined by reports of asthma attacks, symptoms or treatments in the last 12 months. Inflammatory phenotypes were based on low (L) and high (H) blood (B) eosinophil (E) (LBE/HBE:
Relation: info:eu-repo/semantics/altIdentifier/pmid/35152149; hal-03604103; https://hal.science/hal-03604103; https://hal.science/hal-03604103/document; https://hal.science/hal-03604103/file/main%20%284%29.pdf; PUBMED: 35152149; PUBMEDCENTRAL: PMC8844864
الرقم المعرف: 10.1016/j.ebiom.2022.103875
Rights: http://creativecommons.org/licenses/by-nc-nd/ ; info:eu-repo/semantics/OpenAccess
الرقم المعرف: edsbas.3561D119
Processing Request
No Comments.